These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 13814944)

  • 21. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization.
    Marder VJ; Shulman NR; Carroll WR
    J Biol Chem; 1969 Apr; 244(8):2111-9. PubMed ID: 4238527
    [No Abstract]   [Full Text] [Related]  

  • 22. WIDELY DISTRIBUTED NECROTIZING ARTERITIS INDUCED IN RABBITS BY EXPERIMENTAL RENAL ALTERATIONS. IV. DEMONSTRATION OF DECREASED AMOUNT OF THROMBIN CLOTTABLE PLASMA PROTEIN DURING DEVELOPMENT OF THE ARTERIAL LESIONS.
    CAMPBELL WG; SANTOS BUCH CA
    Am J Pathol; 1965 Jan; 46(1):71-83. PubMed ID: 14253131
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunochemical studies on proteins important in blood coagulation.
    BARNHART MI; ANDERSON GF; BAKER WJ
    Thromb Diath Haemorrh; 1962 Oct; 8():21-36. PubMed ID: 13969409
    [No Abstract]   [Full Text] [Related]  

  • 24. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
    Bilezikian SB; Nossel HL; Butler VP; Canfield RE
    J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
    KOLLER F
    Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
    [No Abstract]   [Full Text] [Related]  

  • 26. [USE OF A PHOTOMETRIC METHOD FOR THE STUDY OF COAGULATION AND FIBRINOLYSIS].
    GRUENDLINGER J; BOUVIER CA
    Thromb Diath Haemorrh; 1964 Dec; 12():423-51. PubMed ID: 14254702
    [No Abstract]   [Full Text] [Related]  

  • 27. ANTICOAGULANT ACTIVITY OF DIGEST PRODUCTS OF FIBRINOGEN BY PLASMIN.
    MAKI M; KIKUCHI I; MURAKAMI A
    Tohoku J Exp Med; 1964 Dec; 84():201-14. PubMed ID: 14242745
    [No Abstract]   [Full Text] [Related]  

  • 28. [THE LIVER AND BLOOD COAGULATION].
    LOMAZOVA KhD
    Usp Sovrem Biol; 1963; 56():418-30. PubMed ID: 14150464
    [No Abstract]   [Full Text] [Related]  

  • 29. THE ACTIVATION OF PROACCELERIN.
    DE BERGSAGEL DE; NOCKOLDS ER
    Br J Haematol; 1965 Jul; 11():395-410. PubMed ID: 14317432
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of fibrinolysin on the coagulability of fibrinogen.
    TRIANTAPHYLLOPOULOS DC; GREENE TL; TRIANTAPHYLLOPOULOS E
    Thromb Diath Haemorrh; 1962 Jul; 7():421-31. PubMed ID: 13922452
    [No Abstract]   [Full Text] [Related]  

  • 31. [State of the thrombin-plasmin system in nephrotoxic nephritis treated with heparin, urokinase, and uroplasmin].
    Monastyrskiĭ VA; Ambarova LI
    Arkh Patol; 1980; 42(1):17-22. PubMed ID: 6445726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravascular coagulation-fibrinolysis (ICF) syndrome.
    Owen CA; Bowie EJ
    Ann Clin Lab Sci (1971); 1972; 2(1):26-30. PubMed ID: 4263611
    [No Abstract]   [Full Text] [Related]  

  • 33. ROLE OF PLATELET FIBRINOGEN IN THE REACTIONS OF PLATELETS TO THROMBIN.
    MORSE EE; JACKSON DP; CONLEY CL
    J Clin Invest; 1965 May; 44(5):809-16. PubMed ID: 14276138
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitory effect of "late" type fibrinogen degradation products (FDP) upon the ethanol gelation of plasma.
    Sas G; Blaskó G; Jákó J; Bánhegyi D
    Haematologia (Budap); 1973; 7(3):369-74. PubMed ID: 4275193
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the influence of the administration of trypsin or plasmin on the plasma fibrinogen content in rabbits].
    MORIYA M
    Nihon Seirigaku Zasshi; 1961 Mar; 23():147-60. PubMed ID: 13772702
    [No Abstract]   [Full Text] [Related]  

  • 36. Defibrination and the hypercoagulable state: a model using papain in rabbits.
    Soong BC; Miller SP
    Am J Physiol; 1972 May; 222(5):1113-20. PubMed ID: 5022370
    [No Abstract]   [Full Text] [Related]  

  • 37. Antihemophilic factor-like activity of lysed fibrinogen.
    Triantaphyllopoulos DC; Triantaphyllopoulos E
    Life Sci; 1967 Mar; 6(6):601-8. PubMed ID: 4226767
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of ketone bodies on fibrinogen, thrombocytes, and fibrinolysin activity in rabbits.
    BRAHMANKAR DM; NATH MC
    Am J Physiol; 1963 Apr; 204():653-4. PubMed ID: 14014885
    [No Abstract]   [Full Text] [Related]  

  • 39. The structure of the fibrinogen degradation products.
    Marder VJ; Budzynski AZ
    Prog Hemost Thromb; 1974; 2(0):141-74. PubMed ID: 4137300
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy--a porcine model.
    Fries D; Haas T; Klingler A; Streif W; Klima G; Martini J; Wagner-Berger H; Innerhofer P
    Br J Anaesth; 2006 Oct; 97(4):460-7. PubMed ID: 16885172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.